Skip to main content

Harvard Bioscience Acquires BioRobotics for $3.2M

NEW YORK, Sept. 22 (GenomeWeb News) - Harvard Bioscience said Friday that its Genomic Solutions subsidiary had acquired microarray instrumentation firm BioRobotics, a subsidiary of Apogent Technologies, for approximately $3.2 million in cash and certain limited liabilities.

BioRobotics sells robotics for DNA microarray manufacturing and colony picking. Jeff Williams, president of Genomic Solutions, said the Cambridge, UK-based firm's product line would complement that of GeneMachines, a company it acquired last March for $8.3 million, with "GeneMachines' strength in high-capacity arrayers and BioRobotics' strength in bench top instruments."

Williams said that BioRobotics' UK-based support and sales staff will join Genomic Solutions' UK sales and marketing team, while product development and manufacturing will be consolidated into the company's Huntingdon, UK facility.

BioRobotics is expected to achieve revenues of approximately $3 million in 2004.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.